Relationship between ERCC5 promoter polymorphism and chemosensitivity of oxaliplatin-based chemotherapy in patients with advanced colorectal cancer

doi:10.3969/j.issn.1009-0460.2009.10.002

Home>Articles>Relationship between ERCC5 promoter polymorphism and chemosensitivity of oxaliplatin-based chemotherapy in patients with advanced colorectal cancer

DOI: 10.3969/j.issn.1009-0460.2009.10.002

Relationship between ERCC5 promoter polymorphism and chemosensitivity of oxaliplatin-based chemotherapy in patients with advanced colorectal cancer

Machine-generated Keywords：

Publication Date：2009-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 870-874 )

CHINESE CLINICAL ONCOLOGY

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2009,14(10)